Skip to main content
. 2017 May 17;8(46):80286–80294. doi: 10.18632/oncotarget.17925

Table 3. Adverse events occurring at any grade in the study subjects (n = 50).

All grades, no. (%) Grade ≥ 3, no. (%)
Hematologic
 Leukopenia 46 (92) 23 (46)
 Neutropenia 39 (78) 23 (46)
 Anemia 50 (100) 3 (6)
 Thrombocytopenia 33 (66) 2 (4)
 Febrile neutropenia 5 (10) 5 (10)
Nonhematologic
 Anorexia 26 (52) 2 (4)
 Constipation 33 (66) 0 (0)
 Mucosal inflammation 21 (42) 0 (0)
 Esophagitis 31 (62) 0 (0)
 Fatigue 24 (48) 2 (4)
 Nausea 27 (54) 2 (4)
 Vomiting 9 (18) 0 (0)
 Diarrhea 5 (10) 0 (0)
 Pyrexia 14 (28) 0 (0)
 Elevated AST 12 (24) 0 (0)
 Elevated ALT 18 (36) 0 (0)
 Increased total bilirubin 9 (18) 0 (0)
 Increased creatinine 17 (34) 2 (4)
 Hyperkalemia 29 (58) 1 (2)
 Hyponatremia 31 (62) 8 (16)
 Pneumonitis 8 (16) 1 (2)
 Esophageal perforation 3 (6) 3 (6)
 Pericardial effusion 6 (12) 0 (0)

Abbreviations: AST, aspartate aminotransferase; ALT, alanine aminotransferase.